BCBS gives Cologuard positive review: 3 key notes

Blue Cross Blue Shield Association’s Center for Clinical Effectiveness positively reviewed Madison, Wis.-based Exact Sciences’ Cologuard, a fecal-based colonoscopy alternative.

Advertisement

Here’s what you need to know.

1. The association represents 36 Blue Cross and Blue Shield companies.

2. Approximately two thirds of all BCBS companies cover Cologuard.

3. Exact Sciences CEO Kevin Conroy said the review “affirms that Cologuard has a positive impact on health outcomes and provides additional support for the remaining plans to offer their members our patient-friendly non-invasive colon cancer screening option.”

More articles on gastroenterology/endoscopy:
Dr. J. Calvin Coffey urges classification new abdominal organ: 5 things to know
GI leader to know: Dr. Joseph Binns of Red Bank Gastroenterology
Methodist Dallas Medical Center pancreatitis program earns rare Joint Commission seal: 3 key notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.